Next Monday, Halliburton (NYSE: HAL ) will release its latest quarterly results. The key to making smart investment decisions on stocks reporting earnings is to anticipate how they'll do before they announce results, leaving you fully prepared to respond quickly to whatever inevitable surprises arise. That way, you'll be less likely to make an uninformed knee-jerk reaction to news that turns out to be exactly the wrong move.
Halliburton has thrived in the U.S. energy boom, but weak energy prices have raised questions about whether production activity will decline and cause a drop in demand for oil services. Let's take an early look at what's been happening with Halliburton over the past quarter and what we're likely to see in its quarterly report.
Stats on Halliburton
Analyst EPS Estimate
$0.57
Change From Year-Ago EPS
Top 5 High Dividend Companies To Invest In Right Now: Capella Education Company(CPLA)
Capella Education Company operates as an online postsecondary education services company in the United States and internationally. The company, trough its Capella University, offers various doctoral, master?s, and bachelor?s programs primarily for working adults in public service leadership, behavioral health and human services, business management and technology, and education markets; and online distance learning services for degree-entry programs and doctoral level programs in various disciplines, including business, management, psychology, law, and computing disciplines. It also provides learner support services, such as academic services comprising new learner orientation, technical support, academic advising, research services, online tutoring, and writing services; and administrative services through the telephone and Internet. In addition, the company?s learner support services include library services, such as access to collection of online journals, eBooks, an d interlibrary loan services; and career center services comprising career counseling, job search advising, and career management support services to learners and alumni. As of December 31, 2011, the company offered approximately 1,450 online courses and 43 academic programs with 140 specializations to approximately 37,000 learners. Capella Education Company was founded in 1991 and is headquartered in Minneapolis, Minnesota.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Capella Education (Nasdaq: CPLA ) , whose recent revenue and earnings are plotted below.
10 Best Oil Service Stocks To Own Right Now: Rexahn Pharmaceuticals Inc (RNN)
Rexahn Pharmaceuticals, Inc. (Rexahn) is a development-stage biopharmaceutical company. The Company focuses on the development of cures for cancer to patients worldwide. The Company�� pipeline features one drug candidate in Phase II clinical trials. The Company also has several other drug candidates in pre-clinical development. In addition, the Company has two renal cell carcinoma (CNS) candidates, Serdaxin, CNS Disorders drug for depression and neurodegenerative diseases and Zoraxel, which is a erectile dysfunction (ED) and sexual dysfunction drug that are in clinical stages and the Company is are exploring options for further development . The Company�� drug candidate, Archexin is an anticancer Akt inhibitor.
Archexin
Archexin is potent inhibitor of the Akt protein kinase (Akt) in cancer cells. Archexin has FDA orphan drug designations for five cancers (RCC, glioblastoma, and cancers of the ovary, stomach and pancreas). Multiple indications for other solid tumors can also be pursued. Archexin inhibit both activated and inactivated forms of Akt, and to reverse the drug resistance observed with the protein kinase inhibitors. Archexin is an antisense oligonucleotide (ASO) compound that is complementary to Akt mRNA, and selective for inhibiting mRNA expression and production of Akt protein. As of December 31, 2011, Archexin was in Phase II clinical trials for the treatment of pancreatic cancer with enrollment completed in September, 2011.
Serdaxin
Serdaxin is an extended release formulation of clavulanic acid, which is an ingredient present in antibiotics approved by the FDA. The Company had been developing Serdaxin for the treatment of depression and neurodegenerative disorders. From January to September, 2011, the Company conducted a randomized, double-blind, placebo-controlled study compared two doses of Serdaxin, 0.5 milligram and 5 milligram, to placebo over an eight-week treatment period for major depressive disorder (MDD) patients. As of Dec! ember 31, 2011, the Company had not made a determination of Serdaxin�� future paths or resource allocations to further develop Serdaxin to treat MDD.
Zoraxel
Zoraxel is an orally administered, on-demand tablet to treat sexual dysfunction. Zoraxel is a dual enhancer of neurotransmitters in the brain that play a key role in sexual activity phases of motivation and arousal, erection and release, and may be the ED drug to affect all three of these phases of sexual activity. As of December 31, 2011, the Company was evaluating how to proceed with the Phase IIb study of Zoraxel.
The Company�� Pre-clinical Pipeline Drug Candidates includes RX-1792, which is a small molecule anticancer EGFR inhibitor; RX-5902, which is a small molecule anticancer ribonucleic acid (RNA) helicase regulator; RX-3117, which is a Small molecule anticancer deoxyribonucleic acid (DNA) synthesis Inhibitor; RX-8243, which is a small molecule anticancer aurora kinase inhibitor; RX-0201-Nano, which is a nanoliposomal anticancer Akt inhibitor; RX-0047-Nano, which is an nanoliposomal anticancer HIF-1 alpha inhibitor and RX-21101, which is a nano-polymer Anticancer.
Advisors' Opinion:- [By James E. Brumley]
If you were lucky enough to step into Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) when your truly suggested it was a budding buy back on December 23rd, then congratulations - you're now up a little more than 60% (assuming you bought into RNN after the break above a key resistance line on the 27th). Now get out. Instead, use your profits from the Rexahn to take on a stake in GTx, Inc. (NASDAQ:GTXI). No, GTXI may not look like much at first, but when you take a step back and look at a chart of GTx, Inc. through a longer-term lens, the upside potential becomes clear.
- [By James E. Brumley]
With just a quick glance at a chart of Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN), it would be easy to conclude it's nothing but a volatile mess. When you take a step back and look at a long-term weekly chart of RNN, however, it starts to become clear that this small cap biopharma name is on the verge of a monster-sized breakout. First things first, however.
10 Best Oil Service Stocks To Own Right Now: Taubman Centers Inc (TCO)
Taubman Centers, Inc. (TCO), incorporated November 21, 1973, operates as a self-administered and self-managed real estate investment trust (REIT). The Taubman Realty Group Limited Partnership (TRG) is a subsidiary of TCO that owns direct or indirect interests in all of its real estate properties. The Company owns, leases, acquires, disposes of, develops, expands and manages regional and super-regional shopping centers and interests therein. As of December 31, 2012, the Company owned a portfolio of 24 urban and suburban shopping centers in 12 states. The consolidated Businesses consist of shopping centers and entities that are controlled by ownership or contractual agreements, The Taubman Company LLC (Manager), and Taubman Properties Asia LLC and its subsidiaries (Taubman Asia). In December 2012, it acquired additional 49.9% (100% in total) interest in International Plaza, located in Tampa, Florida. Also in December 2012, it acquired additional 25% (50% in total) interest in Waterside Shops. In January 2014, Taubman Centers Inc announced the completion of the sale of land owned by Taubman in Syosset, New York, and Taubman's interest in Arizona Mills to Simon Property Group.
The Company�� centers are located in metropolitan areas, including Charlotte, Dallas, Denver, Detroit, Los Angeles, Miami, Nashville, New York City, Orlando, Phoenix, San Francisco, Tampa, and Washington, D.C. The centers range in size between 236,000 and 1.6 million square feet of gross leasable area (GLA) and between 186,000 and 646,000 square feet of Mall GLA. Of the 24 centers, 18 are super-regional shopping centers. The Company�� centers have approximately 3,000 stores operated by their mall tenants under approximately 850 trade names. The centers have 65 anchors, operating under 14 trade names. The centers lease over 95% of leased Mall GLA to national chains, including subsidiaries or divisions of Forever 21 (Forever 21, For Love 21, XXI Forever, and others), The Gap (Gap, Gap Kids, Baby Gap, Banana Republic, ! Old Navy, and others), and Limited Brands (Bath & Body Works/White Barn Candle, Pink, Victoria's Secret, and others).
Advisors' Opinion:- [By Rich Duprey]
Shopping-mall operator�Taubman Centers� (NYSE: TCO ) �announced yesterday�its second-quarter dividend of $0.50 per share, the same rate it paid last quarter after raising the payout 8%, from $0.4625 per share.
- [By Marc Bastow]
Super-regional shopping center real estate investment trust (REIT) Taubman Centers (TCO) raised its quarterly dividend 8% to 54 cents per share, payable March 31 to shareholders of record as of March 17.
TCO Dividend Yield: 3.12%
10 Best Oil Service Stocks To Own Right Now: Mattress Firm Holding Corp (MFRM)
Mattress Firm Holding Corp. (Mattress Firm), incorporated on January 5, 2007, is a specialty retailer of mattresses and related products and accessories in the United States. The Company conducts its operations through its indirect, wholly owned subsidiary, Mattress Holding Corp. and its subsidiaries. As of August 2, 2011, the Company and its franchisees operated 620 and 107 stores, respectively, primarily under the Mattress Firm name, in 60 markets across 25 states. The Company focuses on the national brands, but also offers its customers its Hampton and Rhodes private label mattresses. The Company has introduced its YuMe brand. On October 15, 2010, the Company acquired Peak Management, LLC. On December 1, 2010, the Company acquired Maggie's Enterprises, Inc. In May 2012, Mattress Firm announced the completion of its acquisition of regional bedding company, Mattress Giant Holding Corp. Effective September 9, 2013, Mattress Firm Holding Corp, a unit of JW Childs Associates LP, acquired Olejo Inc, a provider of ecommerce retail services.
The Company�� stores carry national mattress brands, with a range of styles, sizes, price points and features. The Company provides its customers with their choice of traditional mattresses, including Sealy and Simmons, as well as specialty mattresses, such as Tempur-Pedic. In addition to its mattress selection, the Company offers a range of bedding-related products and accessories.
Conventional Mattresses
Conventional mattresses, such as those of Sealy (including Sealy Posturepedic and Stearns and Foster) and Simmons (including Simmons Beautyrest), utilize steel-coil innersprings. During the fiscal year ended February 1, 2011, the conventional mattresses represented approximately 75% of bedding industry sales in the United States and approximately 60% of the Company�� total sales. In addition to these national brands, the Company also offers its Hampton and Rhodes private label mattresses.
Specialty Mattresses
Specialty mattresses, such as those manufactured by Tempur-Pedic and select comfort, utilize materials other than steel-coil innersprings to provide comfort and support. In fiscal 2010, the specialty mattresses represented approximately 30% of the Company�� total sales. The Company is expanding its assortments in the categories, including viscoelastic foam mattresses and yume sleep system. Viscoelastic foam, also referred to as memory foam or polyurethane foam, features a temperature sensitive foam core that reduces pressure points and tossing and turning by contouring to one's body. The Company has introduced a sleep system made of foam produced from coconut oil, utilizing a technology that uses ambient air to heat and cool the mattress surface.
Furniture and Accessories
During fiscal 2010, the Company was in the process of introducing new headboards and footboards, which complement its current bedding products. All of the Company�� stores carry an assortment of bedding-related accessories, including bed frames, mattress pads and pillows. In fiscal 2010, bedding-related products and accessories represented approximately 7% of the Company�� total sales from Company-operated stores.
The Company competes with Mattress Giant, American Mattress, Haverty's, Rooms-To-Go, Macy's, Sears, JC Penney, Walmart, Costco and Original Mattress.
Advisors' Opinion:- [By Rick Munarriz]
Tuesday
Mattress Firm (NASDAQ: MFRM ) hopes investors sleep well after checking out its latest quarterly report. The leading retailer of bedding has made the most of its publicly traded status by acquiring smaller rivals in the highly fragmented mattress retailing market. It may also be seen as a housing play if folks moving or buying new properties decide that paying movers to haul over an old mattress may not be worth it. - [By Anna Prior]
Mattress Firm Holding Corp.'s(MFRM) fiscal third-quarter earnings rose 46% as increased advertising helped drive customer traffic and sales growth. The company’s adjusted profit and revenue beat expectations.
10 Best Oil Service Stocks To Own Right Now: PIMCO Intermediate Municipal Bond Strategy Fund (MUNI)
PIMCO Intermediate Municipal Bond Strategy Fund, formerly, PIMCO Intermediate Municipal Bond ETF (the Fund), seeks to achieve its investment objective by investing at least 80% of its assets in a diversified portfolio of debt securities whose interest is, in the opinion of bond counsel for the issuer at the time of issuance, exempt from federal income tax (Municipal Bonds). Municipal Bonds are issued by or on behalf of states and local governments and their agencies, authorities and other instrumentalities. The Fund may only invest in the United States dollar-denominated investment grade debt securities, rated Baa or higher by Moody��, or equivalently rated by S&P or Fitch. It may invest 25% or more of its total assets in Municipal Bonds that finance similar projects, such as those relating to education, health care, housing, transportation and utilities. The Fund�� investment advisor is Pacific Investment Management Company LLC (PIMCO). Advisors' Opinion:- [By Mary Anne & Pamela Aden]
The ones we like best and recommend buying are the iShares 20+ year Treasury Bond (TLT), the iShares 10-20 year Treasury Bond (TLH), Proshares Ultra 20+ year Treasury (UBT) and Pimco Intermediate Muni Bond strategy ETF (MUNI).
10 Best Oil Service Stocks To Own Right Now: SIGA Technologies Inc.(SIGA)
SIGA Technologies, Inc., a pharmaceutical company, engages in the development and commercialization of pharmaceutical solutions for smallpox, Ebola, dengue, Lassa fever, and other dangerous viruses. Its lead product is ST-246, an orally administered antiviral drug that targets orthopoxviruses. The company also has two drug series in the pre-clinical development stage against four serotypes of virus for dengue disease. In addition, it is developing anti-arenavirus drug for hemorrhagic fever arenaviruses and other hemorrhagic fever viruses, including Rift Valley Fever, Lymphocytic choriomeningitis virus, and Ebola; and a broad spectrum antiviral candidate against viruses in the Poxviridae, Filoviridae, Bunyaviridae, Arenaviridae, Flaviviridae, Togaviridae, Retroviridae, and Picornaviridae families. The company was founded in 1995 and is headquartered in New York, New York.
Advisors' Opinion:- [By Monica Gerson]
SIGA Technologies (NASDAQ: SIGA) is expected to post its Q4 earnings at $0.62 per share on revenue of $47.00 million.
Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets
- [By Roberto Pedone]
Another under-$10 name pharmaceutical player that's starting to move within range of triggering a big breakout trade is Siga Technologies (SIGA), which discovers, develops, manufactures and commercializes drugs to prevent and treat diseases including smallpox, Ebola, dengue, Lassa fever and other dangerous viruses. This stock is off to a strong start in 2013, with shares up by 35%.
If you take a look at the chart for SIGA Technologies, you'll notice that this stock has been trending inside of a consolidation pattern for the last two months, with shares moving between $3.16 on the downside and $3.74 on the upside. Shares of SIGA have just started to spike higher above its 50-day moving average at $3.27 a share and it's now moving within range of triggering a big breakout trade above the upper-end of its recent range.
Market players should now look for long-biased trades in SIGA if it manages to break out above some near-term overhead resistance levels at $3.70 to $3.74 a share and then once it takes out more resistance at $4 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 263,209 shares. If that breakout triggers soon, then SIGA will set up to re-test or possibly take out its 52-week high at $4.60 a share. If that level gets taken out with volume, then SIGA could easily tag its next major overhead resistance levels at $5 to $5.90 a share.
Traders can look to buy SIGA off weakness to anticipate that breakout and simply use a stop that sits right below its 200-day moving average of $3.26 a share, or below more key support at $3.16 a share. One can also buy SIGA off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
10 Best Oil Service Stocks To Own Right Now: AMERIPRISE FINANCIAL SERVICES INC. (AMP)
Ameriprise Financial Inc., through its subsidiaries, provides a range of financial products and services in the United States and internationally. The company�s Advice and Wealth Management segment offers financial planning and advice, as well as brokerage and banking services primarily to retail clients through its financial advisors. The Asset Management segment provides investment advice and investment products to retail and institutional clients. The Annuities segment offers variable and fixed annuity products to retail customers through affiliated and unaffiliated advisors, and financial institutions. The Protection segment provides various protection products through financial advisors to address the protection and risk management needs of retail clients, including life, disability income, and property-casualty insurance. The company was formerly known as American Express Financial Corporation and changed its name to Ameriprise Financial, Inc. in September 2005. Ame riprise Financial Inc. was founded in 1894 and is headquartered in Minneapolis, Minnesota.
Advisors' Opinion:- [By Jeff Reeves]
Founded in 1894, Ameriprise Financial (AMP) has a long history as a financial services business but only recently has been trading on the NYSE in its current formation after a 2005 spinoff from American Express (AXP).
- [By Dimitra DeFotis]
Apartment Invest & Management (AIV)
Ameriprise (AMP)
Edison International (EIX)
Host Hotels & Resorts (HST)
Kimco Realty (KIM)
Kroger (KR)
Lincoln National (LNC)
Newfield Exploration (NFX)
Republic Services (RSG)
UnitedHealth (UNH)
Verizon (VZ)
Wells Fargo (WFC)
WellPoint (WLP)
Wyndham Worldwide (WYN)
Xcel Energy Utilities (XEL) - [By U.S. News]
Getty Images Borrowers have been enjoying historically low interest rates since the Great Recession hit. For those with solid credit histories, taking out a mortgage, auto loan or personal loan has never been cheaper. But all that could change. Rates on 30-year fixed-rate mortgages have started creeping upward, and financial experts say other forms of debt could soon follow suit. "We do anticipate rates going up, but how far and how fast that's going to happen is an open question," says Bradley Roth, managing partner at Kattan Ferretti Financial, a Pittsburgh-based financial planning and investment advisory firm. He expects the rates on 10-year Treasurys, which are currently approaching 3 percent, to reach 3.25 percent before the end of the year and then 4 to 4.25 percent in 2014. A rise in interest rates could soon be reflected throughout the entire financial services space, from credit cards to personal loans to home equity lines of credit. The good news for savers is that rates on deposit accounts could also climb after years of very low, or no, rates of return. Here's a roundup of how to prepare for rising rates, depending on your own money identity: For Savers "Savers should be able to benefit," Roth says, because he expects the rates on certificates of deposit, savings accounts and money market accounts to all go up. However, he warns savers against locking up their money in longer-term products, like CDs, which can make it harder to take advantage of quickly rising rates. Any rise in savings rates, though, will likely come slowly, says Greg McBride, senior financial analyst for Bankrate.com. "The Federal Reserve is still 18 to 24 months away from boosting short-term rates, so that will keep a lid on the savings yield," he says. In the meantime, with deposit rate accounts still low, savers can maximize their rate of return by shopping around, says Richard Barrington, senior financial analyst at MoneyRates.com. Online banks tend to offer higher r
- [By Ian Katz]
��he consumer is still in a holding pattern, still waiting for better employment prospects,��said Russell Price, senior economist at Ameriprise Financial Inc. (AMP) in Detroit.
No comments:
Post a Comment